A phase 1, open-label, perioperative study of ivosidenib (AG-120) and vorasidenib (AG-881) in Recurrent IDH1 mutant, low-grade glioma: Updated results Meeting Abstract

   

Authors:	Mellinghoff, I.; Cloughesy, T.; Wen, P.; Taylor, J.; Maher, E.; Arrillaga-Romany, I.; Peters, K.; Choi, C.; Ellingson, B.; Lin, A.; Thakur, S.; Nicolay, B.; Lu, M.; Le, K.; Yin, F.; Tai, F.; Schoenfeld, S.; Pandya, S. S.; Hassan, I.; Steelman, L.; Clarke, J.
Abstract Title:	A phase 1, open-label, perioperative study of ivosidenib (AG-120) and vorasidenib (AG-881) in Recurrent IDH1 mutant, low-grade glioma: Updated results
Meeting Title:	24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Journal Title:	Neuro-Oncology
Volume:	21
Issue:	Suppl. 6
Meeting Dates:	2019 Nov 22-24
Meeting Location:	Phoenix, AZ
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2019-11-01
Start Page:	vi28
Language:	English
ACCESSION:	WOS:000509478700108
PROVIDER:	wos
PMCID:	PMC6847677
DOI:	10.1093/neuonc/noz175.107
Notes:	Meeting Abstract: ACTR-66 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/162550